Display options
Share it on

J Vet Intern Med. 2014 May-Jun;28(3):857-62. doi: 10.1111/jvim.12339. Epub 2014 Mar 05.

Influence of beta blockers on survival in dogs with severe subaortic stenosis.

Journal of veterinary internal medicine

B D Eason, D M Fine, D Leeder, C Stauthammer, K Lamb, A H Tobias

Affiliations

  1. College of Veterinary Medicine, University of Missouri, Columbia, MO.

PMID: 24597738 PMCID: PMC4895480 DOI: 10.1111/jvim.12339

Abstract

BACKGROUND: Subaortic stenosis (SAS) is one of the most common congenital cardiac defects in dogs. Severe SAS frequently is treated with a beta adrenergic receptor blocker (beta blocker), but this approach largely is empirical.

OBJECTIVE: To determine the influence of beta blocker treatment on survival time in dogs with severe SAS.

METHODS: Retrospective review of medical records of dogs diagnosed with severe, uncomplicated SAS (pressure gradient [PG] ≥80 mmHg) between 1999 and 2011.

RESULTS: Fifty dogs met the inclusion criteria. Twenty-seven dogs were treated with a beta blocker and 23 received no treatment. Median age at diagnosis was significantly greater in the untreated group (1.2 versus 0.6 years, respectively; P = .03). Median PG at diagnosis did not differ between the treated and untreated groups (127 versus 121 mmHg, respectively; P = .2). Cox proportional hazards regression was used to identify the influence of PG at diagnosis, age at diagnosis, and beta blocker treatment on survival. In the all-cause multivariate mortality analysis, only age at diagnosis (P = .02) and PG at diagnosis (P = .03) affected survival time. In the cardiac mortality analysis, only PG influenced survival time (P = .03). Treatment with a beta blocker did not influence survival time in either the all-cause (P = .93) or cardiac-cause (P = .97) mortality analyses.

CONCLUSIONS: Beta blocker treatment did not influence survival in dogs with severe SAS in our study, and a higher PG at diagnosis was associated with increased risk of death.

Copyright © 2014 by the American College of Veterinary Internal Medicine.

Keywords: Atenolol; Congenital heart disease

References

  1. J Vet Intern Med. 1994 Nov-Dec;8(6):423-31 - PubMed
  2. J Am Coll Cardiol. 2006 Aug 1;48(3):e1-148 - PubMed
  3. Am J Cardiol. 1985 Dec 1;56(15):989-93 - PubMed
  4. J Vet Cardiol. 2012;14(2):351-61 - PubMed
  5. Vet Rec. 2012 Jun 9;170(23):597 - PubMed
  6. Drugs. 2008;68(5):579-90 - PubMed
  7. J Small Anim Pract. 2012 Apr;53(4):213-6 - PubMed
  8. J Small Anim Pract. 2000 Oct;41(10):451-6 - PubMed
  9. J Am Soc Echocardiogr. 1995 Sep-Oct;8(5 Pt 1):611-20 - PubMed
  10. Cardiovasc Res. 1987 Feb;21(2):124-9 - PubMed
  11. J Vet Intern Med. 2011 May-Jun;25(3):477-83 - PubMed
  12. Circ Res. 1968 Aug;23(2):171-202 - PubMed
  13. J Vet Cardiol. 2000 Dec;2(2):15-22 - PubMed
  14. J Am Vet Med Assoc. 2005 Aug 1;227(3):420-4 - PubMed
  15. Eur J Cardiothorac Surg. 2012 Oct;42(4):S1-44 - PubMed
  16. J Am Vet Med Assoc. 2000 Feb 1;216(3):364-7 - PubMed
  17. Cardiol Young. 2005 Apr;15(2):186-205 - PubMed
  18. Can Vet J. 1989 Oct;30(10):811-5 - PubMed
  19. Circ Res. 1992 Aug;71(2):423-34 - PubMed
  20. Circ Res. 1973 Jul;33(1):34-8 - PubMed
  21. J Vet Intern Med. 1993 Jul-Aug;7(4):247-52 - PubMed
  22. J Pathol Bacteriol. 1967 Jan;93(1):133-40 - PubMed
  23. J Am Coll Cardiol. 1990 Apr;15(5):1157-64 - PubMed
  24. Am Heart J. 1976 Sep;92(3):324-34 - PubMed
  25. Circulation. 1996 Aug 1;94(3):340-5 - PubMed

Substances

MeSH terms

Publication Types